The VHL gene may be useful as a marker gene for the diagnosis of RCC and as a target gene for molecular therapy.
VHL基因可作为临床诊断指标，并可望成为肾透明细胞癌基因治疗的重要目的基因。
This molecular therapy worked about as well as giving mice antidepressants, the researchers reported in the journal Science.
研究人员在《科学》期刊上指出，这种分子治疗就如同给老鼠抗抑郁剂一样有效。
It is a new way for the study of multidrug resistance of leukemia. RNAi may be a new research tool of molecular diagnosis and molecular therapy on leukemia in the future.
该技术为白血病多药耐药的基础和临床研究开辟了新思路，也为新的分子诊断和分子治疗提供可能。
The therapy stems from nearly 20 years of research on hereditary blindness in mice and dogs by Jean Bennett, a molecular geneticist at the University of Pennsylvania School of Medicine.
该疗法源于美国宾夕法尼亚大学医学院的分子遗传学家让·贝内特近20年来对老鼠和狗的遗传性失明的研究。
Researchers don't know yet what sparks cell division at the molecular level, but learning that process and how to control it could lead to a safe, effective stem cell therapy.
研究者还不知道在分子水平是什么激发细胞分裂，但是认识到这个过程以及如何控制它可以通往安全的有效的干细胞治疗道路。
Aim Telomerase is highly expression in most tumor cells, and it is an ideal target for cancer molecular targeting therapy.
目的端粒酶在多种肿瘤细胞中高表达，可能是肿瘤分子靶向治疗的一个理想靶点。
It is a key task for cancer research to search novel prognostic marker, improve early diagnostic rate, and new target of molecular targeted therapy of gastric cancer.
因此提高胃癌的早期诊断率、寻找新的治疗靶点及预后指标，是当前肿瘤研究的重要课题。
The study of its electrophysiological mechanism and molecular etiology supplies plenty of academic basis to therapy of atria fibrillation.
研究房颤的电生理分子病因学方面的机制，将为其治疗提供较多理论基础和依据。
AIM: To observe the clinical effect of combination therapy with ozagrel and low molecular weight heparin on progressive cerebral infarction.
目的：观察奥扎格雷钠、低分子肝素钠联合应用治疗进展性脑梗死的临床疗效。
With deeper cognition about mechanisms of disease at the cellular and molecular level, gene therapy has become one of the most important research fields in medical molecular biology at present.
随着在细胞分子水平上对疾病发病机制认识的深入，基因治疗已成为目前医学分子生物学最重要的研究领域之一。
Conclusion. The genes identified in this study, especially those involved in pain signaling and inflammation, serve as potential targets for molecular-based therapy for lumbar radiculopathy.
结论：本研究中鉴别的基因尤其是疼痛信号和炎症相关基因可能是腰神经病分子治疗的潜在靶点。
To investigate the molecular mechanism of th may reveal the pathogenic mechanism of mitochondrial diseases and provide the molecular basis for diagnosis and gene therapy.
TH分子机制的研究将有助于揭示这些线粒体疾病的致病机理以及为其诊断和基因治疗提供分子依据。
These studies indicated a potential value of PDCD4 as a molecular target in cancer therapy.
研究显示，PDCD4基因在肿瘤治疗中作为一种分子治疗靶向的可能性。
KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.
KRAS基因突变在恶性肿瘤组织中频发，可预测非小细胞肺癌分子靶向治疗的疗效和预后，针对RAS基因的分子抑制剂研究仍处于初级阶段。
Results Extended radical resection, neoadjuvant chemotherapy, orthotopic liver transplantation, photodynamic therapy and molecular chemoradiotherapy might improve the survival rate.
结果扩大根治切除、新辅助放疗化疗、原位肝移植、光动力学治疗和分子放化疗均能有效地提高患者的生存率。
Objective to get an insight into the molecular mechanisms of diseases development and targeted therapy at the transcriptome level and search for potential therapeutic targets.
目的在转录组水平全面迅速地了解疾病发生和药物作用的分子机理，以及寻找潜在的治疗靶标。
AIM: To study the specificity of the expression of PEG10 in HCC tissues and evaluate the feasibility for PEG10 as a novel molecular target of gene therapy for HCC.
目的：研究遗传印记基因PEG10在肝癌组织中表达的特异性，及在不同肿瘤细胞中的表达情况，为其作为一个潜在的肝癌特异标志物和HCC基因治疗的新的分子靶点提供实验依据。
Some molecular and genetic markers might predict whether colorectal cancer patients are likely to benefit from adjuvant or salvage therapy.
一些分子或基因指标有可能预测大肠患者能否从辅助化疗或姑息化疗中获益。
Molecular targeted therapy has limited or nonexistent side effects on normal cells of the body, unlike traditional chemotherapy.
分子靶向治疗比传统的化疗特异性强、毒副反应小，将成为今后肿瘤治疗的新趋势。
Small dosage of low molecular weight heparin, parenteral nutritional support and somatostatin therapy have the therapeutical effects to some extent.
小剂量低分子肝素、胃肠外营养及生长抑素的联合应用具有较佳的疗效。
With the flying development and progress of molecular-biology, the genetic research and genetic therapy of AMD turn into a current hotspot.
随着分子生物学的飞速发展与进步，AMD的基因研究与基因治疗成为当前的研究热点。
Conclusion it is quite effective, convenient, safe, economical and commendatory to use aspirin and low molecular weight heparin in acute cerebral infarction therapy.
结论使用肠溶阿司匹林和低分子肝素钙联合治疗急性脑梗塞疗效好，使用简便、安全、经济，可在临床予推广应用。
Works on the genetic and epigenetic research of complex diseases, such as lung cancer and scleroderma, as well as the molecular mechanism of Chinese traditional medicine in scleroderma therapy.
主要从事肺癌、硬皮病等复杂多基因疾病的遗传学及表观遗传学研究及中药治疗硬皮病的分子作用机理研究。
Complementary to and based on traditional diagnostic pathology, molecular oncologic pathology further predicts the biological behavior of a given tumor and also guides the therapy.
分子肿瘤病理学与传统肿瘤病理学不但相辅相成，而且能在传统肿瘤病理学的基础上进一步预测肿瘤的生物学行为及指导治疗。
Conclusions FHIT and WWOX are candidate tumor suppressor genes. Detected coordinately with other (molecular) parameters, they can make the prognosis of therapy more accurate to predict.
结论FHIT和WWOX基因系重要的候选抑瘤基因，与其他预后指标的联合检测可望对患者的治疗预后作出更准确的预测。
The molecular targeted therapy for esophageal cancer, still in its infancy, is also an important area of the study in future esophageal cancer treatment.
而对于食管癌的分子靶向治疗，目前尚处于萌芽阶段，也是食管癌治疗研究的重点，并具有广阔的前景。
In recent years, molecular targeted therapy has become a hot spot.
近年来分子靶向治疗逐渐成为研究热点。
Objective To observe the influence of low molecular weight heparin on cerebral blood flow and brain function in patients with acute cerebral infarction in different therapy time window.
目的研究不同时间窗低分子量肝素治疗急性脑梗死的疗效及其对患者脑血流量和脑电图的影响。
Objective To observe the influence of low molecular weight heparin on cerebral blood flow and brain function in patients with acute cerebral infarction in different therapy time window.
目的研究不同时间窗低分子量肝素治疗急性脑梗死的疗效及其对患者脑血流量和脑电图的影响。
应用推荐